By: Emily Fu North River Leerink (NRL) has announced that 100 Chestnut, a purpose-built 200,000 square feet life Science building in Somerville, MA, is 90% leased. Ultragenyx, relocating from Kendall Square, has leased 42,500 square feet to consolidate their east coast R&D. CRADL has leased 16,000 square feet to open a contract vivarium and in […]
By Hannah Green A Framingham-based biotech is relocating its headquarters to a new space closer to the center of Massachusetts’ biotech industry. BPGbio announced on Wednesday it was moving into 70,000 square feet of lab and office space at 300 Third Avenue in Waltham. The biotech company plans to move into two full floors of the […]
By Richard Berger There are early signs of recovery within the life sciences environment following a recent investment slowdown as venture capital is re-emerging, tenants are coming off the sidelines and average deal sizes are hitting all-time highs, according to a recent report from Cushman & Wakefield. Its research manager, Sandy Romero, said venture capital […]
By Rowan Walrath In a first for the Nobel Prize-winning gene-editing technology, a CRISPR-based drug has been approved in the U.S. The Food and Drug Administration gave the green light Friday to exa-cel, a drug made by two Boston-based companies, Vertex Pharmaceuticals Inc. (Nasdaq: VRTX) and CRISPR Therapeutics Inc. (Nasdaq: CRSP). It will be marketed under […]
By Rowan Walrath Somerville’s bluebird bio Inc. has won its third U.S. drug approval since splitting into two companies. On Friday, the Food and Drug Administration approved lovo-cel, a gene therapy for sickle-cell disease. The drug will be marketed under the name Lyfgenia. The FDA announced Lyfgenia’s approval at the same time it said it had approved […]
By Rowan Walrath A consortium of leaders in the private and public sectors are making a push for Massachusetts to play host to a hub of a new, biomedical research-focused federal agency. ARPA-H, short for the Advanced Research Projects Agency for Health, is tasked with kickstarting biomedical innovation. While its home base will be in the […]
By Rowan Walrath Massachusetts’ life sciences industry grew by more than 7,000 jobs last year, outpacing competitor states even as the so-called “Covid boom” began to wane. That’s according to the latest “Industry Snapshot” report put out by the Massachusetts Biotechnology Council, the trade group better known as MassBio, which examines trends in workforce, real estate, […]
By Rowan Walrath Massachusetts leaders want to make the commonwealth a hub for not just the research of drugs, but for the manufacturing of drugs. It’s a goal that’s seen progress in stops and starts before. The Genetics Institute Inc., the legendary Cambridge company that pioneered biomedical research in the early 1980s, set up shop in […]
By Gail Kalinoski Pharmaceutical and biotechnology company Moderna has acquired a newly built 140,000-square-foot Boston-area GMP facility from developer Oxford Properties Group for $91 million. The 24-acre parcel, acquired as a vacant site by Oxford in 2021, is located at 149 Hayes Memorial Drive in Marlborough, Mass., a Boston submarket. Oxford built a two-story biomanufacturing facility that was designed to […]
By Greg Ryan Consigli Construction Co. last week topped off a nine-story lab building under development from CV Properties and Cannon Hill Capital Partners in Somerville’s Union Square. Boynton Gateway, as the 336,000-square-foot project located at 495 Columbia St. is known, is one of several lab projects at various stages of development in the neighborhood. Union […]
